Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
- PMID: 32794443
- PMCID: PMC7427299
- DOI: 10.2807/1560-7917.ES.2020.25.32.2001410
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
Erratum in
-
Authors' correction for Euro Surveill. 2020;25(32).Euro Surveill. 2020 Aug;25(33):200820c. doi: 10.2807/1560-7917.ES.2020.25.33.200820c. Euro Surveill. 2020. PMID: 32820717 Free PMC article. No abstract available.
Abstract
We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.
Keywords: COVID-19; Europe; NGS; SARS-CoV-2; WGS; nomenclature; sequencing.
Conflict of interest statement
Figures



Similar articles
-
Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type.Indian J Med Res. 2020 May;151(5):450-458. doi: 10.4103/ijmr.IJMR_1125_20. Indian J Med Res. 2020. PMID: 32474553 Free PMC article.
-
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.J Transl Med. 2020 Apr 22;18(1):179. doi: 10.1186/s12967-020-02344-6. J Transl Med. 2020. PMID: 32321524 Free PMC article.
-
SARS-CoV-2 sequencing: The technological initiative to strengthen early warning systems for public health emergencies in Latin America and the Caribbean.Biomedica. 2020 Oct 30;40(Supl. 2):188-197. doi: 10.7705/biomedica.5841. Biomedica. 2020. PMID: 33152203 Free PMC article. English, Spanish.
-
The genetic sequence, origin, and diagnosis of SARS-CoV-2.Eur J Clin Microbiol Infect Dis. 2020 Sep;39(9):1629-1635. doi: 10.1007/s10096-020-03899-4. Epub 2020 Apr 24. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32333222 Free PMC article. Review.
-
Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.Front Immunol. 2020 Sep 11;11:552909. doi: 10.3389/fimmu.2020.552909. eCollection 2020. Front Immunol. 2020. PMID: 33013925 Free PMC article. Review.
Cited by
-
Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.Rev Med Virol. 2021 Nov;31(6):e2231. doi: 10.1002/rmv.2231. Epub 2021 Mar 16. Rev Med Virol. 2021. PMID: 33724631 Free PMC article. Review.
-
'Geno-to-pheno' SARS-CoV-2 genome-COVID-19 association studies.EBioMedicine. 2021 Apr;66:103333. doi: 10.1016/j.ebiom.2021.103333. Epub 2021 Apr 12. EBioMedicine. 2021. PMID: 33857904 Free PMC article. No abstract available.
-
Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines.Biomed Pharmacother. 2021 Apr;136:111272. doi: 10.1016/j.biopha.2021.111272. Epub 2021 Jan 12. Biomed Pharmacother. 2021. PMID: 33486212 Free PMC article. Review.
-
Genomic epidemiology of SARS-CoV-2 infections in The Gambia: an analysis of routinely collected surveillance data between March, 2020, and January, 2022.Lancet Glob Health. 2023 Mar;11(3):e414-e424. doi: 10.1016/S2214-109X(22)00553-8. Lancet Glob Health. 2023. PMID: 36796985 Free PMC article.
-
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.Clin Microbiol Rev. 2021 May 12;34(3):e00228-20. doi: 10.1128/CMR.00228-20. Print 2021 Jun 16. Clin Microbiol Rev. 2021. PMID: 33980687 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous